220 related articles for article (PubMed ID: 9142061)
1. Randomised double-blind placebo-controlled study on adverse effects of rubella immunisation in seronegative women.
Tingle AJ; Mitchell LA; Grace M; Middleton P; Mathias R; MacWilliam L; Chalmers A
Lancet; 1997 May; 349(9061):1277-81. PubMed ID: 9142061
[TBL] [Abstract][Full Text] [Related]
2. Risk of chronic arthropathy among women after rubella vaccination. Vaccine Safety Datalink Team.
Ray P; Black S; Shinefield H; Dillon A; Schwalbe J; Holmes S; Hadler S; Chen R; Cochi S; Wassilak S
JAMA; 1997 Aug; 278(7):551-6. PubMed ID: 9268275
[TBL] [Abstract][Full Text] [Related]
3. Rubella virus vaccine associated arthropathy in postpartum immunized women: influence of preimmunization serologic status on development of joint manifestations.
Mitchell LA; Tingle AJ; Grace M; Middleton P; Chalmers AC
J Rheumatol; 2000 Feb; 27(2):418-23. PubMed ID: 10685808
[TBL] [Abstract][Full Text] [Related]
4. Postpartum rubella immunization: association with development of prolonged arthritis, neurological sequelae, and chronic rubella viremia.
Tingle AJ; Chantler JK; Pot KH; Paty DW; Ford DK
J Infect Dis; 1985 Sep; 152(3):606-12. PubMed ID: 4031558
[TBL] [Abstract][Full Text] [Related]
5. Rubella vaccination in Australia: 2. Experience with the RA27/3 rubella vaccine and results of a double-blind trial in schoolgirls.
Menser MA; Forrest JM; Bransby RD; Collins E
Med J Aust; 1978 Jul; 2(3):85-8. PubMed ID: 362141
[TBL] [Abstract][Full Text] [Related]
6. [Studies on rubella vaccination in adult females. I: Clinical and laboratory studies on clinical reactions].
Nakazono N
Hokkaido Igaku Zasshi; 1984 Mar; 59(2):180-91. PubMed ID: 6745839
[TBL] [Abstract][Full Text] [Related]
7. HLA-DR class II associations with rubella vaccine-induced joint manifestations.
Mitchell LA; Tingle AJ; MacWilliam L; Horne C; Keown P; Gaur LK; Nepom GT
J Infect Dis; 1998 Jan; 177(1):5-12. PubMed ID: 9419163
[TBL] [Abstract][Full Text] [Related]
8. Clinical laboratory evaluation of rubella virus vaccine given to postpartum women without pregnancy preventive.
Villarejos VM; Arguedas JA; Hernandez GC; Buynak EB; Hilleman MR
Obstet Gynecol; 1973 Nov; 42(5):689-95. PubMed ID: 4749573
[No Abstract] [Full Text] [Related]
9. Postpartum immunization with rubella virus vaccine and antibody response in breast-feeding infants.
Krogh V; Duffy LC; Wong D; Rosenband M; Riddlesberger KR; Ogra PL
J Lab Clin Med; 1989 Jun; 113(6):695-9. PubMed ID: 2732617
[TBL] [Abstract][Full Text] [Related]
10. Studies on the reactogenicity and immunogenicity of the BRD-2 and RA27/3 live attenuated rubella vaccines.
Wang SS; Han YR; Su WN; Chen J; Zhao K
Vaccine; 1984 Dec; 2(4):277-80. PubMed ID: 6531968
[TBL] [Abstract][Full Text] [Related]
11. A controlled comparison of joint reactions among women receiving one of two rubella vaccines.
Polk BF; Modlin JF; White JA; DeGirolami PC
Am J Epidemiol; 1982 Jan; 115(1):19-25. PubMed ID: 7034531
[TBL] [Abstract][Full Text] [Related]
12. Absence of an association between rubella vaccination and arthritis in underimmune postpartum women.
Slater PE; Ben-Zvi T; Fogel A; Ehrenfeld M; Ever-Hadani S
Vaccine; 1995 Nov; 13(16):1529-32. PubMed ID: 8578837
[TBL] [Abstract][Full Text] [Related]
13. Prospective evaluation of pregnant women vaccinated against rubella in southern Brazil.
Minussi L; Mohrdieck R; Bercini M; Ranieri T; Sanseverino MT; Momino W; Callegari-Jacques SM; Schuler-Faccini L
Reprod Toxicol; 2008 Jan; 25(1):120-3. PubMed ID: 17977696
[TBL] [Abstract][Full Text] [Related]
14. Rubella prevention in family practice with RA27/3 vaccine.
Hansen NH
J Fam Pract; 1980 Oct; 11(4):537-42. PubMed ID: 7420029
[TBL] [Abstract][Full Text] [Related]
15. Development of immunoglobulin M-antibodies after rubella immunization with RA27/3 attenuated live vaccine in teen-agers: remaining problems.
Braito A; Fanti O; Rossolini GM; Cellesi C
Boll Ist Sieroter Milan; 1991-1992; 70(1-2):443-8. PubMed ID: 1670047
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with clinical reactions to rubella vaccination in women.
Nakazono N; Fujimoto S; Wakisaka A; Ishii K; Ichinoe K; Aizawa M
Int J Gynaecol Obstet; 1987 Jun; 25(3):207-16. PubMed ID: 2886379
[TBL] [Abstract][Full Text] [Related]
17. Post-partum vaccination of rubella-susceptible women.
Horstmann DM; Liebhaber H; Kohorn EI
Lancet; 1970 Nov; 2(7681):1003-6. PubMed ID: 4098042
[No Abstract] [Full Text] [Related]
18. Some current issues relating to rubella vaccine.
Preblud SR
JAMA; 1985 Jul; 254(2):253-6. PubMed ID: 3999370
[TBL] [Abstract][Full Text] [Related]
19. Trials with a live attenuated rubella virus vaccine, Cendehill strain.
Grant L; Belle EA; Provan G; King SD; Sigel MM
J Hyg (Lond); 1970 Sep; 68(3):505-10. PubMed ID: 5272349
[TBL] [Abstract][Full Text] [Related]
20. Arthritis after rubella vaccination of women.
Gold JA
N Engl J Med; 1969 Jul; 281(2):109. PubMed ID: 5784773
[No Abstract] [Full Text] [Related]
[Next] [New Search]
